| Autor: |
Sathya, D., Sathya, D., Rashid, M., Kaufmann, B. |
| Zdroj: |
Annals of Allergy, Asthma & Immunology; November 2024, Vol. 133 Issue: 6, Number 6 Supplement 1 pS162-S163, 2p |
| Abstrakt: |
Vaccine-induced Immune Thrombotic Thrombocytopenia(VITT) is a clinical syndrome of systemic thrombosis and thrombocytopenia occurring between 4-42 days after COVID-19 vaccination. VIIT is very rare, with the highest incidence with adenoviral vaccines (AstraZeneca, J&J/Janssen vaccine - 20.3 and 4 per million individuals, respectively). Only 4 cases of VIIT after mRNA vaccines (Moderna, Pfizer-BioNTech) have been identified in literature. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
